C-B5LQsiRNA, gene network reset, machine learning
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Develop an siRNA therapeutic program for neurodegenerative disease involving dysregulated gene networks.
siRNA therapeutic candidate discovery through the RESET platform using human disease data, genetics, and machine learning.
Listed in Junevity's pipeline.
Develop an siRNA therapeutic program for obesity as a complex age-related disease involving gene dysregulation.
siRNA therapeutic candidate discovery through the RESET platform using human disease data, genetics, and machine learning.
Listed in Junevity's pipeline.
Discover siRNA therapeutic candidates that reset dysregulated gene networks implicated in complex age-related diseases.
Uses human disease data, genetics, machine learning, and siRNA to identify targets capable of restoring dysregulated gene networks toward a healthy state.
Platform described as Junevity's therapeutic discovery engine for age-related disease programs.
Founders reportedly showed that repression of a single transcription factor can restore gene networks to a healthy state in a human cell model of aging.
Develop an siRNA therapeutic program for type 2 diabetes as an age-related disease involving gene dysregulation.
siRNA therapeutic candidate discovery through the RESET platform using human disease data, genetics, and machine learning.
Listed in Junevity's pipeline.